Sovaldi

See the following -

Ebola In West Africa Is A Wake-Up Call

Els Torreele | Aljazeera English | November 6, 2014

Eight months into the world's worst Ebola outbreak, we have lost 5,000 lives and expect to see more infections and deaths in the coming months. The reason is simple: We have no drug to cure Ebola, or vaccine to prevent it...

Read More »

Hepatitis C Drug Costing VA, DoD Millions

Patricia Kime | Military Times | January 7, 2015

One of the costliest drugs on the market threatens the Veterans Affairs Department's health budget — to the point that VA, which added the medication to its formulary in April, provides it to only the sickest patients who need it...

Read More »

On the Lack of Good Medical Evidence for the New $100,000 Hepatitis C Drug Treatments

As we wrote, most recently last week, the hepatitis C screening and treatment bandwagon keeps rolling along.  There is constant public argument whether about the prices of treatment regimens, which approach $100,000 per patient in the US...However, starting in March, 2014, we have posted about the lack of good evidence from clinical research suggesting these drugs are in fact so wondrous...

Read More »

Serious Risks and Few New Benefits from FDA-Approved Drugs

Donald W. Light | Health Affairs Blog | July 6, 2015

Over the past year, the U.S. Senate and The New York Times have been investigating the failure of the nation’s auto safety regulators to protect citizens from cars with occasionally dangerous faulty devices. But neither august institution has paid attention to the Food and Drug Administration’s (FDA) failure to protect the 170 million Americans who take prescription drugs from adverse reactions that are killing more than 2,400 people every week. Annually, prescription drugs cause over 81 million adverse reactions and result in 2.7 million hospitalizations...

Read More »